How to Help Your Patients Save Money on Collagenase: A Provider's Guide to Savings Programs

Medication Cost Is One of the Biggest Barriers to Wound Care Adherence

You've assessed the wound, determined that enzymatic debridement with Collagenase (Santyl) is the right clinical choice, and written the prescription. But here's the reality: if your patient can't afford to fill it, the prescription is just a piece of paper.

Collagenase is an effective and well-established treatment for chronic wound debridement, but it comes with a significant price tag — and there's no generic alternative. For patients without adequate insurance coverage, the cost can be the difference between a healing wound and one that deteriorates.

This guide is designed for wound care specialists, dermatologists, podiatrists, primary care physicians, and other prescribers who want to help their patients navigate the financial side of Collagenase treatment. We'll cover what patients are actually paying, available savings programs, and practical strategies for building cost conversations into your workflow.

What Patients Are Paying for Collagenase

Understanding the financial landscape helps you anticipate which patients will need extra support:

Cash Prices (Uninsured)

• 30g tube: $333 to $450+
• 90g tube: $800 to $1,200+

For a patient who needs ongoing treatment — say, daily application for 4-8 weeks — the cost adds up quickly. A single 30g tube may last only 2-3 weeks depending on wound size, meaning patients can easily spend over $1,000 out of pocket before debridement is complete.

With Insurance

Most commercial plans, Medicare Part D, and Medicaid cover Santyl, but coverage typically requires prior authorization. Key points:

• Prior auth is usually approved for 3-month periods for documented chronic dermal ulcers or burns
• Step therapy may be required by some payers — patients may need to demonstrate failure of other debridement methods first
• Copays can still be significant, particularly for patients on high-deductible plans or specialty tiers
• Quantity limits may apply — some plans limit to one 30g tube per fill

The Adherence Impact

Research consistently shows that medication cost is a top predictor of non-adherence. For wound care, non-adherence doesn't just mean slower healing — it can mean wound deterioration, infection, hospitalization, and in severe cases, amputation. The financial investment in helping patients access affordable Collagenase pays dividends in clinical outcomes.

Manufacturer Savings Programs

Smith+Nephew, the manufacturer of Santyl, offers two primary programs:

Santyl Copay Assistance Card

This is the first option to consider for commercially insured patients:

• How it works: Eligible patients pay the first $50 per fill, and Smith+Nephew covers up to the next $250
• Annual limit: Up to 6 fills per year, with a $1,000 annual maximum benefit
• Eligibility: Commercially insured and uninsured patients
• Not eligible: Medicare, Medicaid, TRICARE, VA, or other government insurance beneficiaries
• How to enroll: Patients can register at santyl.com or by calling the number on the Santyl website

Clinical tip: Keep copay card information in your office or wound care center. Hand it to the patient with the prescription — don't assume they'll find it on their own. Many patients don't know manufacturer savings programs exist.

Smith+Nephew Patient Assistance Program (PAP)

For patients who are uninsured, underinsured, or experiencing financial hardship:

• How it works: Provides Santyl at no cost to eligible patients
• Eligibility: Low-income, uninsured, or underinsured patients who meet income requirements
• How to apply: Through santyl.com or by contacting Smith+Nephew directly. Applications typically require income documentation.
• Processing time: Can take several weeks — plan ahead when possible

Clinical tip: If you know a patient is uninsured before prescribing, initiate the PAP application at the same appointment. Having a staff member assist with the paperwork increases completion rates significantly.

Coupon and Discount Cards

Beyond the manufacturer programs, several third-party platforms offer discounts on Collagenase:

Pharmacy Discount Programs

• GoodRx — Shows pricing across pharmacies and may offer coupons that reduce the cash price
• SingleCare — Similar coupon-based discount program
• RxSaver — Compares prices and provides discount cards
• Optum Perks — Offers discounted pricing at participating pharmacies

These programs are most useful for uninsured patients or those whose insurance doesn't cover Santyl. The discounts vary by pharmacy and location, but can sometimes reduce the price by 10-25%.

Limitations to Note

• Discount cards typically cannot be combined with insurance copay benefits
• Prices change frequently — patients should check at the time of fill
• Not all pharmacies participate in all discount programs
• These discounts are generally smaller than the manufacturer copay card benefit for insured patients

For a comprehensive list of savings options, direct patients to our patient guide to saving money on Collagenase.

Generic Alternatives and Therapeutic Substitution

Generic Collagenase

As of 2026, there is no generic version of Collagenase (Santyl). Patents extend to at least 2030. This means therapeutic substitution — not generic substitution — is the relevant conversation when cost is prohibitive.

Alternative Debridement Options

When cost makes Collagenase impractical, consider these alternatives based on clinical appropriateness:

• Autolytic debridement with hydrogel dressings (Intrasite Gel, SAF-Gel) — Significantly cheaper, though slower. Appropriate for wounds with light to moderate necrotic tissue and when time is not a critical factor.
• Medihoney (medical-grade Manuka honey) — Provides autolytic and osmotic debridement with antimicrobial properties. Available OTC and generally less expensive than Santyl.
• Surgical/sharp debridement — No medication cost, but requires provider time and appropriate setting. May be covered differently by insurance (as a procedure rather than a prescription).
• NexoBrid (Anacaulase-bcdb) — A newer enzymatic debriding agent for deep burns. Different indication profile and cost structure.

Clinical considerations: The choice of debridement method should always be clinically driven first, with cost as a secondary factor. However, an affordable treatment the patient actually uses will outperform an expensive one they can't fill. For more on alternatives, see our alternatives guide.

Building Cost Conversations Into Your Workflow

Many providers feel uncomfortable discussing medication costs, but your patients are silently struggling with them. Here are practical strategies:

At the Point of Prescribing

1. Mention the cost proactively. "Santyl is an effective treatment, but I want you to know it's expensive — a tube can cost over $300 without help. Let me show you some options to bring that down."
2. Hand them the copay card. Keep Santyl Copay Assistance Card information at the point of care. A 10-second handoff can save your patient hundreds of dollars.
3. Ask about insurance. "Do you have prescription coverage? Let me check if we need a prior authorization."
4. Initiate prior auth early. Don't wait for the pharmacy to reject the claim. If you know Santyl typically requires PA with the patient's insurer, start the process at the appointment.

For Uninsured or Underinsured Patients

1. Start the PAP application at the visit. Have forms available and a staff member ready to assist.
2. Bridge the gap. While PAP applications process, consider starting with a lower-cost debridement method (hydrogel dressings) and transitioning to Santyl once assistance is approved.
3. Direct them to resources. Patient assistance databases like RxAssist (rxassist.org) and NeedyMeds (needymeds.org) can identify additional programs.

For Your Clinical Team

1. Train staff on savings programs. Front desk and nursing staff should know about the copay card and PAP and be able to walk patients through them.
2. Create a wound care cost resource sheet. A single-page handout listing savings programs, phone numbers, and websites saves time and improves patient outcomes.
3. Track prior auth status. Designate someone on your team to follow up on PA requests so patients don't fall through the cracks.

Leverage Technology

• Medfinder for Providers — Helps you and your patients find pharmacies with Collagenase in stock, compare pricing, and access savings resources
• Electronic prior authorization (ePA) — If your EHR supports it, use electronic PA to speed up the approval process
• Benefit verification tools — Many EHR systems now include real-time benefit checks that show patient cost estimates at the point of prescribing

Final Thoughts

The cost of Collagenase is a real barrier to treatment adherence, and addressing it is part of providing complete wound care. The good news is that between manufacturer savings programs, discount cards, patient assistance programs, and thoughtful therapeutic substitution, most patients can access the treatment they need at a price they can manage.

The most impactful thing you can do is simple: bring up cost before your patient leaves the office. A 60-second conversation about savings options can prevent a prescription from going unfilled — and a wound from getting worse.

For provider resources and tools to help your patients find Collagenase in stock, visit Medfinder for Providers.